Inhibition of ischemia-induced fodrin breakdown by a novel phenylpyrimidine derivative NS-7: An implication for its neuroprotective action in rats with middle cerebral artery occlusion

Journal of Neurochemistry

Volumn 68, Issue 6, 1997, Pages 2507-2513

  Takagaki, Yumiko ^a   Itoh, Yoshinori ^a   Aoki, Yasuaki ^a   Ukai, Yojiro ^a   Yoshikuni, Yoshiaki ^a   Kimura, Kiyoshi ^a  

^a NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

Calpain; Cerebral cortex; Fodrin breakdown; Infarction; Ischemia; Neuroprotection

Indexed keywords

4 (4 FLUOROPHENYL) 2 METHYL 6 (5 PIPERIDINOPENTYLOXY)PYRIMIDINE; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CALCIUM TRANSPORT; DRUG EFFECT; EXTRACELLULAR CALCIUM; IMMUNOBLOTTING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; RAT;

EID: 0030929915     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68062507.x     Document Type: Article

References (44)

1. Aoki Y., Shibahara R., Itoh Y., Ukai Y., Yoshikuni Y., and Kimura K. (1997) Cerebroprotective effects of NS-7, a novel pyrimidine derivative, in rats after permanent middle cerebral artery occlusion. Jpn. J. Pharmacol. (Suppl.) 73, 90.
2. Arai A., Vanderklish P., Kessler M., Lee K., and Lynch G. (1991) A brief period of hypoxia causes proteolysis of cytoskeletal proteins in hippocampal slices. Brain Res. 555, 276-280.
3. Bahr B. A., Tiriveedhi S., Park G. Y., and Lynch G. (1995) Induction of calpain-mediated spectrin fragments by pathogenic treatments in long-term hippocampal slices. J. Pharmacol. Exp. Ther. 273, 902-908.
4. Bartus R. T., Baker K. L., Heiser A. D., Sawyer S. D., Dean R. L., Elliott P. J., and Straub J. A. (1994a) Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage. J. Cereb. Blood Flow Metab. 14, 537-544.
5. Bartus R. T., Hayward N. J., Elliott P. J., Sawyer S. D., Baker K. L., Dean R. L., Akiyama A., Straub J. A., Harbeson S. L., Li Z., and Powers J. (1994b) Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration. Stroke 25, 2265-2270.
6. Bartus R. T., Dean R. L., Cavanaugh K., Eveleth D., Carriero D. L., and Lynch G. (1995) Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain. J. Cereb. Blood Flow Metab. 15, 969-979.
7. Bederson J. B., Pitts L. H., Tsuji M., Nishimura M. C., Davis R. L., and Bartkowski H. (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17, 472-476.
8. Bradford M. A. (1976) Rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. 72, 248-254.
9. Brorson J. R., Marcuccilli C. J., and Miller R. J. (1995) Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke 26, 1259-1267.
10. 2+-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia. J. Cereb. Blood Flow Metab. 14, 903-910.
11. Choi D. W. (1990) Cerebral hypoxia: some new approaches and unanswered questions. J. Neurosci. 10, 2493-2501.
12. Collingridge G. and Lester R. A. (1989) Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 40, 143-210.
13. 2+-dependent proteases (μ-calpain and m-calpain). J. Biol. Chem. 264, 10096-10103.
14. Fern R., Ransom B. R., Stys P. K., and Waxman S. G. (1993) Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam. J. Pharmacol. Exp. Ther. 266, 1549-1555.
15. Garcia J. H., Liu K.-F., and Ho K.-L. (1995) Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudate putamen and the cortex. Stroke 26, 636-643.
16. Gill R. and Lodge D. (1994) The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia. Neuropharmacology 33, 1529-1536.
17. Graham S. H., Chen J., Sharp F. R., and Simon R. P. (1993) Limiting ischemic injury by inhibition of excitatory amino acid release. J. Cereb. Blood Flow Metab. 13, 88-97.
18. Graham S. H., Chen J., Lan J., Leach M. J., and Simon R. P. (1994) Neuroprotective effect of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion. J. Pharmacol. Exp. Ther. 269, 854-859.
19. Hong S.-C., Goto Y., Lanzino G., Soleau S., Kassell N. F., and Lee K. S. (1994) Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25, 663-669.
20. Inuzuka T., Tamura A., Sato S., Kirino T., Toyoshima I., and Miyatake T. (1990) Suppressive effect of E-64c on ischemic degradation of cerebral proteins following occlusion of the middle cerebral artery in rats. Brain Res. 526, 177-179.
21. Johnson G. V. W., Litersky J. M., and Jope R. S. (1991) Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J. Neurochem. 56, 1630-1638.
22. Kanai Y., Smith C. P., and Hediger M. A. (1993) A new family of neurotransmitter transporters: the high-affinity glutamate transporters. FASEB J. 7, 1450-1459.
23. Kiedrowski L., Wroblewski J. T., and Costa E. (1994) Intracellular sodium concentration in cultured cerebellar granule cells challenged with glutamate. Mol. Pharmacol. 45, 1050-1054.
24. Kishimoto A., Mikawa K., Hashimoto K., Yasuda I., Tanaka S., Tominaga M., Kuroda T., and Nishizuka Y. (1989) Limited proteolysis of protein kinase C by calcium-activated neutral protease (calpain). J. Biol. Chem. 264, 4088-4092.
25. Koch R. A. and Barish M. E. (1994) Perturbation of intracellular calcium and hydrogen ion regulation in cultured mouse hippocampal neurons by reduction of the sodium ion concentration gradient. J. Neurosci. 14, 2585-2593.
26. Leach M. J., Swan J. H., Eisenthal D., Libiol M. D., and Nobbs M. (1993) BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke 24, 1063-1067.
27. Lynch J. J., Yu S. P., Canzoniero L. M. T., Sensi S. L., and Choi D. W. (1995) Sodium channel blockers reduce oxygen-glucose deprivation-induced cortical neuronal injury when combined with glutamate receptor antagonists. J. Pharmacol. Exp. Ther. 273, 554-560.
28. + channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke 25, 2476-2482.
29. McDonald J. W. and Johnston M. V. (1990) Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. 15, 41-70.
30. Meldrum B. S., Swan J. H., Leach M. J., Millan M. H., Gwinn R., Kadota K., Graham S. H., Chen J., and Simon R. P. (1992) Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87. Brain Res. 593, 1-6.
31. Neumar R. W., Hagle S. M., DeGracia D. J., Krause G. S., and White B. C. (1996) Brain μ-calpain autolysis during global cerebral ischemia. J. Neurochem. 66, 421-424.
32. Nicholls D. and Attwell D. (1990) The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11, 462-468.
33. 2+ in toxic cell killing. Trends Pharmacol. Sci. 10, 281-285.
34. Rami A. and Krieglstein J. (1993) Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res. 609, 67-70.
35. Saido T. C., Yokota M., Nagao S., Yamaura I., Tani E., Tsuchiya T., Suzuki K., and Kawashima S. (1993) Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 268, 25239-25243.
36. Saido T. C., Sorimachi H., and Suzuki K. (1994) Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8, 814-822.
37. Shimidzu T., Itoh Y., Tatsumi S., Hayashi S., Ukai Y., Yoshikuni Y., and Kimura K. (1997) Blockade of voltage-sensitive sodium channels by NS-7, a novel neuroprotective compound, in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. (in press).
38. 2+] in hypoxia and ischemia in rat brain in vivo. J. Gen. Pharmacol 95, 837-866.
39. 2+ channel blocking actions of NS-7, a novel cerebroprotective compound. Jpn. J. Pharmacol. (Suppl.) 73, 193.
40. Szatkowski M., Barbour B., and Attwell D. (1990) Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 348, 443-446.
41. Tamura A., Graham D. I., McCulloch J., and Teasdale G. M. (1981) Focal cerebral ischemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1, 53-60.
42. + channels as targets for neuroprotective drugs. Trends Pharmacol. Sci. 16, 309-316.
43. 2+ chelators. J. Cereb. Blood Flow Metab. 14, 911-923.
44. Wang K. K. W. and Yuen P.-W. (1994) Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol. Sci. 15, 412-419.